MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Paroxysmal dystonia with phenotypic variability in ECHS1 mutation twin carriers

G. Bonato, M. Nosadini, S. Andretta, A. Suppiej, A. Leon, S. Sartori, M. Carecchio (Padua, Italy)

Meeting: 2022 International Congress

Abstract Number: 842

Keywords: Mitochondria, Paroxysmal dyskinesia

Category: Rare Genetic and Metabolic Diseases

Objective: To describe 2 monozygotic twins carrying biallelic ECHS1 mutations with different clinical phenotypes

Background: ECHS1 encodes for a mitochondrial short chain enoyl-CoA hydratase, a key component of degradation of fatty acids and essential amino acids. Biallelic mutations are associated with a rare congenital neurometabolic disorder with a heterogeneous clinical spectrum, featuring severe developmental delay, psychomotor regression, dystonia and seizures; paroxysmal dyskinesia has rarely been reported. Onset is classically in childhood, presentation after 8 years has not been documented so far. Brain MRI usually shows subcortical white matter alterations and pallidal involvement with Leigh-like features

Method: We describe 2 monozygotic twin girls aged 16 with clinical assessment, MRI imaging and genetic testing

Results: The first twin presented mild developmental delay and paroxysmal episodes of generalized painful dystonia from 18 months of age. Dystonic attacks started in the lower limbs with a caudo-cranial spreading to the trunk, neck and upper limbs leading to opisthotonic posturing and head hyperextension. Triggers included prolonged physical exercise, temperature changes and hot water; duration was up to one hour and remission was favored by rest. Carbamazepine significantly reduced frequency, severity and anatomical extension of the attacks. Mild intellectual disability (IQ53) was documented during adolescence. At age 14 years, the second twin started complaining of mild episodes of exercise-induced foot dystonia, with occasional painful involvement of the homolateral upper limb. Cognition was normal. Carbamazepine abolished the attacks. Genetic analysis (WES) demonstrated heterozygous mutations in ECHS1 gene: c.518C>T p.Ala173Val (previously reported as pathogenic in 4 subjects with early-onset paroxysmal dyskinesia) and c.123_124delAG p.Gly42Glufs*3 (predicted as pathogenic) in both twins. Parents carried a single mutation. Brain MRI showed bilateral pallidal hyperintensity and white matter subtle alterations in both twins.

Conclusion: ECHS1 mutations can rarely cause a mild phenotype of paroxysmal dystonia with a later onset than previously reported and partial overlap with Glut-1 deficiency. The p.Ala173Val mutation is specifically associated with this clinical presentation. Our cases demonstrate intrafamilial clinical heterogeneity even in monozygotic twins with the same radiological alterations on brain MRI

Cattura 1

Cattura 2

Cattura

To cite this abstract in AMA style:

G. Bonato, M. Nosadini, S. Andretta, A. Suppiej, A. Leon, S. Sartori, M. Carecchio. Paroxysmal dystonia with phenotypic variability in ECHS1 mutation twin carriers [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/paroxysmal-dystonia-with-phenotypic-variability-in-echs1-mutation-twin-carriers/. Accessed July 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/paroxysmal-dystonia-with-phenotypic-variability-in-echs1-mutation-twin-carriers/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • #24970 (not found)
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley